CompletedPhase 2NCT03086226
Proof-of-Concept Superiority Trial of Fosravuconazole Versus Itraconazole for Eumycetoma in Sudan
Studying Mycetoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Drugs for Neglected Diseases
- Principal Investigator
- Ahmed Fahal, ProfMycetoma Research Centre, Soba University, Khartoum, Sudan
- Intervention
- Fosravuconazole(drug)
- Enrollment
- 104 enrolled
- Eligibility
- 15 years · All sexes
- Timeline
- 2017 – 2022
Study locations (1)
- Mycetoma Research Centre, Khartoum, Sudan
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03086226 on ClinicalTrials.govOther trials for Mycetoma
Additional recruiting or active studies for the same condition.